Engineered lactic acid bacterium lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha

Applied and Environmental Microbiology

Volumn 76, Issue 20, 2010, Pages 6928-6932

  Ravnikar, Matjaž ^a   Štrukelj, Borut ^a,b   Obermajer, Nataša ^b   Lunder, Mojca ^a   Berlec, Aleš ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; BINDING CAPACITIES; INFLAMMATORY BOWEL DISEASE; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; SIMULATED GASTRIC JUICE; STAPHYLOCOCCAL PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

BODY FLUIDS; GLYCOPROTEINS; LACTIC ACID; MACROPHAGES; TUMORS;

ANTIBODIES;

ANTIBODY; RECOMBINANT PROTEIN; STAPHYLOCOCCUS PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY; BACTERIUM; BIOENGINEERING; DIGESTIVE SYSTEM; DISEASE TREATMENT; PROTEIN; TUMOR;

ARTICLE; GENETICS; LACTOCOCCUS LACTIS; METABOLISM; PROTEIN BINDING;

ANTIBODIES; LACTOCOCCUS LACTIS; PROTEIN BINDING; RECOMBINANT PROTEINS; STAPHYLOCOCCAL PROTEIN A; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; STAPHYLOCOCCUS;

EID: 77958608927     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00190-10     Document Type: Article

References (28)

1. Bosma, T., R. Kanninga, J. Neef, S. A. Audouy, M. L. van Roosmalen, A. Steen, G. Buist, J. Kok, O. P. Kuipers, G. Robillard, and K. Leenhouts. 2006. Novel surface display system for proteins on non-genetically modified grampositive bacteria. Appl. Environ. Microbiol. 72:880-889.
2. Bratkovic, T., A. Berlec, T. Popovic, M. Lunder, S. Kreft, U. Urleb, and B. Strukelj. 2006. Engineered staphylococcal protein A's IgG-binding domain with cathepsin L inhibitory activity. Biochem. Biophys. Res. Commun. 349: 449-453.
3. Charteris, W. P., P. M. Kelly, L. Morelli, and J. K. Collins. 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84:759-768.
4. de Silva, D. G., L. N. Mendis, N. Sheron, G. J. Alexander, D. C. Candy, H. Chart, and B. Rowe. 1992. TNF alpha in stool as marker of intestinal inflammation. Lancet 340:372.
5. de Vrese, M., and J. Schrezenmeir. 2008. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111:1-66.
6. Dieye, Y., S. Usai, F. Clier, A. Gruss, and J. C. Piard. 2001. Design of a protein-targeting system for lactic acid bacteria. J. Bacteriol. 183:4157-4166.
7. Jonsson, A., H. Wallberg, N. Herne, S. Stahl, and F. Y. Frejd. 2009. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol. Appl. Biochem. 54:93-103.
8. Jose, J., J. W. Chung, B. J. Jeon, R. M. Maas, C. H. Nam, and J. C. Pyun. 2009. Escherichia coli with autodisplayed Z-domain of protein A for signal amplification of SPR biosensor. Biosens. Bioelectron. 24:1324-1329.
9. Kruger, C., Y. Hu, Q. Pan, H. Marcotte, A. Hultberg, D. Delwar, P. J. van Dalen, P. H. Pouwels, R. J. Leer, C. G. Kelly, C. van Dollenweerd, J. K. Ma, and L. Hammarstrom. 2002. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol. 20:702-706.
10. Langmuir, I. 1918. The adsorption of gases on plane surfaces of glass, mica and platinum. J. Am. Chem. Soc. 40:1361-1403.
11. Langmuir, I. 1916. The constitution and fundamental properties of solids and liquids. J. Am. Chem. Soc. 38:2221-2295.
12. Le Loir, Y., S. Nouaille, J. Commissaire, L. Bretigny, A. Gruss, and P. Langella. 2001. Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis. Appl. Environ. Microbiol. 67:4119-4127. (Pubitemid 33641707)
13. Mierau, I., and M. Kleerebezem. 2005. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl. Microbiol. Biotechnol. 68:705-717.
14. Miyoshi, A., I. Poquet, V. Azevedo, J. Commissaire, L. Bermudez-Humaran, E. Domakova, Y. Le Loir, S. C. Oliveira, A. Gruss, and P. Langella. 2002. Controlled production of stable heterologous proteins in Lactococcus lactis. Appl. Environ. Microbiol. 68:3141-3146.
15. Moks, T., L. Abrahmsen, B. Nilsson, U. Hellman, J. Sjoquist, and M. Uhlen. 1986. Staphylococcal protein A consists of five IgG-binding domains. Eur. J. Biochem. 156:637-643.
16. Nakamura, Y., S. Shibasaki, M. Ueda, A. Tanaka, H. Fukuda, and A. Kondo. 2001. Development of novel whole-cell immunoadsorbents by yeast surface display of the IgG-binding domain. Appl. Microbiol. Biotechnol. 57:500-505.
17. Nilsson, B., T. Moks, B. Jansson, L. Abrahmsen, A. Elmblad, E. Holmgren, C. Henrichson, T. A. Jones, and M. Uhlen. 1987. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1:107-113.
18. Nord, K., E. Gunneriusson, J. Ringdahl, S. Stahl, M. Uhlen, and P. A. Nygren. 1997. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat. Biotechnol. 15:772-777.
19. Nygren, P. A. 2008. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold. FEBS J. 275:2668-2676.
20. Ohno, K., K. Sawai, Y. Iijima, B. Levin, and D. Meruelo. 1997. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotechnol. 15:763-767.
21. Okano, K., Q. Zhang, S. Kimura, J. Narita, T. Tanaka, H. Fukuda, and A. Kondo. 2008. System using tandem repeats of the cA peptidoglycan-binding domain from Lactococcus lactis for display of both N- and C-terminal fusions on cell surfaces of lactic acid bacteria. Appl. Environ. Microbiol. 74:1117-1123.
22. Paton, A. W., R. Morona, and J. C. Paton. 2006. Designer probiotics for prevention of enteric infections. Nat. Rev. Microbiol. 4:193-200.
23. Sandborn, W. J., and S. B. Hanauer. 1999. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm. Bowel Dis. 5:119-133.
24. Sriraman, K., and G. Jayaraman. 2008. HtrA is essential for efficient secretion of recombinant proteins by Lactococcus lactis. Appl. Environ. Microbiol. 74:7442-7446.
25. Steen, A., G. Buist, G. J. Horsburgh, G. Venema, O. P. Kuipers, S. J. Foster, and J. Kok. 2005. AcmA of Lactococcus lactis is an N- acetylglucosaminidase with an optimal number of LysM domains for proper functioning. FEBS J. 272:2854-2868.
26. van Asseldonk, M., W. M. de Vos, and G. Simons. 1993. Functional analysis of the Lactococcus lactis usp45 secretion signal in the secretion of a homologous proteinase and a heterologous alpha-amylase. Mol. Gen. Genet. 240: 428-434.
27. Wells, J. M., and A. Mercenier. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6:349-362.
28. Worledge, K. L., R. Godiska, T. A. Barrett, and J. A. Kink. 2000. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig. Dis. Sci. 45:2298-2305.